Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[77Br]Br-DAPI is a novel, nanoparticle-encapsulated, bromine-77-labeled derivative of the classic nuclear-staining dye DAPI (4',6-diamidino-2-phenylindole), being developed as a therapeutic radiopharmaceutical for Auger electron nuclear medicine. As an Auger electron emitter, bromine-77 (77Br) delivers high linear energy transfer (LET) radiation over an ultra-short range, making its cytotoxicity highly dependent on precise nuclear localization. While free DAPI has poor membrane permeability in live cells, encapsulating [77Br]Br-DAPI within nanoparticles via a pH gradient loading method significantly enhances its intracellular and nuclear delivery. Once inside the nucleus, the DAPI moiety binds strongly to the minor groove of double-stranded DNA, positioning the 77Br isotope in close proximity to the host genome to induce lethal double-strand DNA breaks. Preclinical studies in cancer cell lines have demonstrated that the nanoparticle formulation of [77Br]Br-DAPI dramatically increases cellular uptake and suppresses cell proliferation, highlighting its potential as a targeted radionuclide therapy for cancer.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [77Br]Br-DAPI.
Work on [77Br]Br-DAPI? Claim this page to correct or add information. Claim this page